AR048875A1 - Un proceso para preparar montelukast y compuestos intermedios para el mismo - Google Patents

Un proceso para preparar montelukast y compuestos intermedios para el mismo

Info

Publication number
AR048875A1
AR048875A1 ARP050101619A ARP050101619A AR048875A1 AR 048875 A1 AR048875 A1 AR 048875A1 AR P050101619 A ARP050101619 A AR P050101619A AR P050101619 A ARP050101619 A AR P050101619A AR 048875 A1 AR048875 A1 AR 048875A1
Authority
AR
Argentina
Prior art keywords
formula
montelukast
compound
same
intermediate compounds
Prior art date
Application number
ARP050101619A
Other languages
English (en)
Inventor
Arjanne Overeem
Reinerus Gerardus Gieling
Zhu Jie
Thijs Lambertus
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of AR048875A1 publication Critical patent/AR048875A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/39—Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un proceso para preparar montelukast y compuestos intermediarios. También se reivindica la obtencion de los intermediarios de formulas (1), (3) y (4). Reivindicacion 1: Un proceso para preparar montelukast o sus sales, caracterizado porque comprende convertir un compuesto de formula (1) en montelukast de formula (2) o una sal del mismo. Reivindicacion 2: El proceso de acuerdo con la reivindicacion 1, caracterizado porque dicha conversion comprende hacer reaccionar dicho compuesto de formula (1) con un compuesto de formula (3), donde R es hidrogeno o un grupo alquilo C1-4 y L es un grupo saliente. Reivindicacion 17: Un compuesto caracterizado por estar seleccionado del grupo formado por los compuestos de formula (1) y de formula (4).
ARP050101619A 2004-04-30 2005-04-25 Un proceso para preparar montelukast y compuestos intermedios para el mismo AR048875A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56660304P 2004-04-30 2004-04-30
US58467504P 2004-07-02 2004-07-02
US11/081,695 US7501517B2 (en) 2004-04-30 2005-03-17 Process for making montelukast and intermediates therefor

Publications (1)

Publication Number Publication Date
AR048875A1 true AR048875A1 (es) 2006-06-07

Family

ID=34972158

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101619A AR048875A1 (es) 2004-04-30 2005-04-25 Un proceso para preparar montelukast y compuestos intermedios para el mismo

Country Status (5)

Country Link
US (1) US7501517B2 (es)
EP (2) EP2181986B1 (es)
AR (1) AR048875A1 (es)
AT (1) ATE529408T1 (es)
WO (1) WO2005105749A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2541994A1 (en) * 2003-10-10 2005-05-06 Arjanne Overeem Solid-state montelukast
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
US7858793B2 (en) * 2004-07-19 2010-12-28 Chava Satyanarayana Methyl 2-[(3S)-[3-[2E)-(7-chloro quinolin-2-yl) ethenyl] phenyl]-3-halopropyl] benzoates
CA2608369A1 (en) 2005-07-05 2007-01-11 Teva Pharmaceutical Industries Ltd. Purification of montelukast
CN101356157B (zh) * 2005-11-18 2011-07-06 斯索恩有限公司 制备孟鲁司特及其中间体的方法
AR056815A1 (es) * 2005-11-18 2007-10-24 Synthon Bv PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST
EA021960B1 (ru) 2005-12-30 2015-10-30 Крка, Товарна Здравил, Д.Д., Ново Место Таблетка, содержащая фармацевтически приемлемую соль монтелукаста в аморфной форме, и способ ее получения
CN101432267A (zh) * 2006-03-17 2009-05-13 斯索恩有限公司 孟鲁司特金刚烷胺盐
EP1886998A1 (en) 2006-08-09 2008-02-13 Esteve Quimica, S.A. Purification process of montelukast and its amine salts
WO2009042984A1 (en) 2007-09-28 2009-04-02 Codexis, Inc. Ketoreductase polypeptides and uses thereof
CN102046602A (zh) * 2008-04-25 2011-05-04 斯索恩有限公司 制备孟鲁司特中间体的方法
US8207343B2 (en) 2008-05-26 2012-06-26 Laurus Labs Private Limited Process for preparing montelukast and salts thereof
EP2552892A1 (en) 2010-03-31 2013-02-06 KRKA, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
HUP1000425A2 (en) 2010-08-11 2012-03-28 Richter Gedeon Nyrt Process for the production of montelukast sodium
US8471030B2 (en) 2010-12-06 2013-06-25 Orochem Technologies Inc. Purification of montelukast using simulated moving bed
CN103467276B (zh) * 2013-09-13 2015-05-06 天津速研医药科技有限公司 一种孟鲁司特钠侧链关键中间体的合成方法
CN111072475A (zh) * 2019-12-20 2020-04-28 牡丹江恒远药业股份有限公司 1-羟甲基环丙基乙酸的合成方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856322A (en) 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5266568A (en) 1990-10-12 1993-11-30 Merck Frosst Canada, Inc. Hydroxyalkylquinoline ether acids as leukotriene antagonists
ES2114882T3 (es) 1990-10-12 1998-06-16 Merck Frosst Canada Inc Acidos hidroxialquilquinolinos insaturados como antagonistas de leucotrienos.
US5565473A (en) 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5270324A (en) 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
TW448160B (en) 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5523477A (en) 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5869673A (en) 1997-02-28 1999-02-09 Merck & Co., Inc. Process for 3-(2-(7-chloro-2-quinolinyl)ethenyl) - benzaldehyde
CN1420113A (zh) * 2001-11-16 2003-05-28 北京上地新世纪生物医药研究所 孟鲁司特钠的制备方法及其制备中间体
CN1171873C (zh) * 2001-12-26 2004-10-20 北京上地新世纪生物医药研究所 一种孟鲁司特钠的制备方法及其制备中间体
US20040265375A1 (en) 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CA2541994A1 (en) 2003-10-10 2005-05-06 Arjanne Overeem Solid-state montelukast
US7829716B2 (en) 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor

Also Published As

Publication number Publication date
WO2005105749A2 (en) 2005-11-10
EP1740546A2 (en) 2007-01-10
ATE529408T1 (de) 2011-11-15
WO2005105749A3 (en) 2006-03-02
US20050245569A1 (en) 2005-11-03
US7501517B2 (en) 2009-03-10
EP2181986B1 (en) 2011-10-19
EP2181986A1 (en) 2010-05-05

Similar Documents

Publication Publication Date Title
AR048875A1 (es) Un proceso para preparar montelukast y compuestos intermedios para el mismo
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
AR055635A1 (es) Uso de sulfonanilidas como herbicidas
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
AR051373A1 (es) Procedimiento para la preparacion de analogos aciclicos de nucleotidos de fosfonatos
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
WO2009156861A3 (en) Substituted pyrimidone derivatives
AR055779A1 (es) Proceso de preparacion de azoxistrobina y composicion que contiene al compuesto
AR048876A1 (es) Un proceso para preparar montelukast y compuestos intermedios para el mismo
UA101482C2 (ru) Способ получения 2'-дезокси-5-азацитидина (децитабина)
IN2014CN04665A (es)
ATE530531T1 (de) Verfahren zur herstellung von bosentan
EA200701738A1 (ru) Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина
UA101712C2 (ru) Способ производства производных замещенной метоксиметилпиридин-2,3-дикарбоновой кислоты
CY1117087T1 (el) Διαδικασια για την παρασκευη εστερων (5-φθορο-2-μεθυλο-3-κινολιν-2-υλμεθυλ-ινδoλ-1-υλ)- οξικου οξεος
AR079294A1 (es) Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos
MA32985B1 (fr) Nouveaux microbiocides
AR051936A1 (es) Proceso para la preparacion de pirazoles
ATE428693T1 (de) Prostaglandinsynthese
PE20060697A1 (es) Un proceso para la preparacion de pirazoles 1,3, 5-trisubstituidos por medio de cicloadicion [3+2]
AR070737A1 (es) Proceso para la elaboracion de (fenilsulfanilfenil) piperidinas
BR112012019620A2 (pt) Processo para preparar voriconazol usando novos intermediários
BRPI0517388B1 (pt) Processo para a preparação de fenil 2-pirimidinil cetonas e seus intermediários
AR047887A1 (es) Procesos para preparar pioglitazona y sus intermediarios

Legal Events

Date Code Title Description
FA Abandonment or withdrawal